Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
68.41
+0.73 (1.08%)
At close: Aug 28, 2025, 4:00 PM
68.45
+0.04 (0.06%)
After-hours: Aug 28, 2025, 5:12 PM EDT
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Soleno Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $112.5, which forecasts a 64.45% increase in the stock price over the next year. The lowest target is $74 and the highest is $145.
Price Target: $112.5 (+64.45%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 4 | 4 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $106 | Strong Buy | Reiterates | $106 | +54.95% | Aug 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $123 | Buy | Initiates | $123 | +79.80% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +60.80% | Aug 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $97 → $106 | Strong Buy | Maintains | $97 → $106 | +54.95% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +60.80% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
144.11M
Revenue Next Year
396.86M
from 144.11M
Increased by 175.39%
EPS This Year
-1.06
from -4.38
EPS Next Year
2.67
from -1.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 177.5M | 579.4M | |
| Avg | 144.1M | 396.9M | |
| Low | 107.3M | 247.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 302.0% | |
| Avg | - | 175.4% | |
| Low | - | 71.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.28 | 5.78 | |
| Avg | -1.06 | 2.67 | |
| Low | -2.25 | 0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.